AU5236893A - Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them - Google Patents
Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing themInfo
- Publication number
- AU5236893A AU5236893A AU52368/93A AU5236893A AU5236893A AU 5236893 A AU5236893 A AU 5236893A AU 52368/93 A AU52368/93 A AU 52368/93A AU 5236893 A AU5236893 A AU 5236893A AU 5236893 A AU5236893 A AU 5236893A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical
- alkyl
- diagnostic
- preparation
- ischemically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C07D213/643—2-Phenoxypyridines; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Benzoylguanidines of the formula I <IMAGE> where R(1) is hydrogen, Hal, -NO2, -C IDENTICAL N, -CF3, R(4)-SOm or R(5)R(6)N-SO2-, R(4) and R(5) being alk(en)yl, or CF3, with R(5) also having the meaning of H, R(2) is heteroaryl, or -SR(10), -OR(10), -NR(10)R(11) or -CR(10)R(11)R(12); where R(10) is -CaH2a-heteroaryl, R(11) and R(12) are defined as R(10) or are hydrogen or alkyl, R(3) is defined as R(1) or is alkyl or -X-R(13), where X is oxygen, S or NR(14), and R(13) is H or (cyclo)alkyl, are described. They are obtained from a compound II <IMAGE> by reaction with guanidine. The compounds are outstandingly suitable for use as anti-arrhythmic drugs (medicaments, pharmaceuticals) having a cardioprotective component for the prophylaxis and treatment of infarction and also for the treatment of angina pectoris, the compounds also inhibiting or strongly reducing, in a preventive manner, the pathophysiological processes associated with the occurrence of ischemically-induced damage, in particular in association with the triggering of ischemically-induced cardiac arrhythmias.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4242191 | 1992-12-15 | ||
DE4242191 | 1992-12-15 | ||
DE4311800 | 1993-04-09 | ||
DE4311800 | 1993-04-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5236893A true AU5236893A (en) | 1994-06-30 |
AU672246B2 AU672246B2 (en) | 1996-09-26 |
Family
ID=25921333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52368/93A Ceased AU672246B2 (en) | 1992-12-15 | 1993-12-13 | Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0602523B1 (en) |
JP (1) | JP3780004B2 (en) |
AT (1) | ATE146170T1 (en) |
AU (1) | AU672246B2 (en) |
CA (1) | CA2111386C (en) |
DE (1) | DE59304748D1 (en) |
DK (1) | DK0602523T3 (en) |
ES (1) | ES2096840T3 (en) |
FI (1) | FI106856B (en) |
GR (1) | GR3022136T3 (en) |
HU (1) | HU217634B (en) |
NO (1) | NO300590B1 (en) |
NZ (1) | NZ250437A (en) |
TW (1) | TW250479B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641792A (en) * | 1994-09-09 | 1997-06-24 | Hoechst Aktiengesellschaft | Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
US5708034A (en) * | 1995-11-03 | 1998-01-13 | Hoechst Aktiengesellschaft | Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
US5731350A (en) * | 1995-11-20 | 1998-03-24 | Hoechst Aktiengesellschaft | Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
US5747541A (en) * | 1995-09-27 | 1998-05-05 | Hoechst Aktiengesellschaft | Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
US5811448A (en) * | 1995-12-14 | 1998-09-22 | Hoechst Aktiengesellschaft | Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof |
US5856344A (en) * | 1995-11-14 | 1999-01-05 | Hoechst Aktiengesellschaft | Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4325822A1 (en) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
DE4344550A1 (en) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Substituted 1-oxo-1,2-dihydro-isoquinolinoyl and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them |
FR2719310B1 (en) * | 1994-04-29 | 1996-07-19 | Hoechst France | New acetaldehyde derivatives, their preparation process and their application. |
DE4421495A1 (en) * | 1994-06-20 | 1995-12-21 | Merck Patent Gmbh | Heterocyclyloxy-benzoylguanidines |
IL114670A0 (en) * | 1994-08-05 | 1995-11-27 | Fujisawa Pharmaceutical Co | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4430212A1 (en) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Ortho-substituted benzoic acid derivatives |
DE4430916A1 (en) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl benzoylguanidine derivatives |
DE4437874A1 (en) * | 1994-10-22 | 1996-04-25 | Merck Patent Gmbh | Alkyl 5-methylsulfonylbenzoylguanidine derivatives |
US6057322A (en) * | 1995-01-30 | 2000-05-02 | Hoechst Aktiengesellschaft | Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
DE59603311D1 (en) * | 1995-01-30 | 1999-11-18 | Hoechst Ag | Basically substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
DE19502895A1 (en) * | 1995-01-31 | 1996-08-01 | Merck Patent Gmbh | 4-mercapto-benzoylguanidine derivatives |
DE19517848A1 (en) * | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorine-containing benzoylguanidines |
DE19738604A1 (en) * | 1997-09-04 | 1999-03-11 | Hoechst Marion Roussel De Gmbh | Use of Na<+>/H<+> exchange inhibitors |
DE19950898A1 (en) | 1999-10-22 | 2001-04-26 | Aventis Pharma Gmbh | New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
DE10226462A1 (en) * | 2002-06-13 | 2003-12-24 | Aventis Pharma Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their use as medicament, and medicament containing them |
WO2004047730A2 (en) * | 2002-11-21 | 2004-06-10 | New York Blood Center | Compounds for inhibition of hiv infection by blocking hiv entry |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3929582A1 (en) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT |
CZ284456B6 (en) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Amino substituted benzylguanidines, process of their preparation and their use for preparing medicaments |
EP0604852A1 (en) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituted 5-(N-substituted-sulfamoyl) benzoylguanidines, as antiarrhythmic agents, inhibitors of the proliferation of cells and inhibitors of sodium-hydrogen exchange |
-
1993
- 1993-10-28 TW TW082108978A patent/TW250479B/zh active
- 1993-12-08 DK DK93119782.6T patent/DK0602523T3/en active
- 1993-12-08 AT AT93119782T patent/ATE146170T1/en not_active IP Right Cessation
- 1993-12-08 ES ES93119782T patent/ES2096840T3/en not_active Expired - Lifetime
- 1993-12-08 EP EP93119782A patent/EP0602523B1/en not_active Expired - Lifetime
- 1993-12-08 DE DE59304748T patent/DE59304748D1/en not_active Expired - Lifetime
- 1993-12-13 NZ NZ250437A patent/NZ250437A/en unknown
- 1993-12-13 AU AU52368/93A patent/AU672246B2/en not_active Ceased
- 1993-12-13 FI FI935578A patent/FI106856B/en active
- 1993-12-14 JP JP31304193A patent/JP3780004B2/en not_active Expired - Fee Related
- 1993-12-14 CA CA002111386A patent/CA2111386C/en not_active Expired - Fee Related
- 1993-12-14 NO NO934604A patent/NO300590B1/en unknown
- 1993-12-14 HU HU9303577A patent/HU217634B/en not_active IP Right Cessation
-
1996
- 1996-12-20 GR GR960403574T patent/GR3022136T3/en unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641792A (en) * | 1994-09-09 | 1997-06-24 | Hoechst Aktiengesellschaft | Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
US5747541A (en) * | 1995-09-27 | 1998-05-05 | Hoechst Aktiengesellschaft | Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
US5708034A (en) * | 1995-11-03 | 1998-01-13 | Hoechst Aktiengesellschaft | Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
US5856344A (en) * | 1995-11-14 | 1999-01-05 | Hoechst Aktiengesellschaft | Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
US5731350A (en) * | 1995-11-20 | 1998-03-24 | Hoechst Aktiengesellschaft | Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
US5811448A (en) * | 1995-12-14 | 1998-09-22 | Hoechst Aktiengesellschaft | Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof |
Also Published As
Publication number | Publication date |
---|---|
EP0602523A1 (en) | 1994-06-22 |
HUT70028A (en) | 1995-09-28 |
NO300590B1 (en) | 1997-06-23 |
TW250479B (en) | 1995-07-01 |
NO934604D0 (en) | 1993-12-14 |
FI106856B (en) | 2001-04-30 |
FI935578A0 (en) | 1993-12-13 |
NZ250437A (en) | 1996-02-27 |
EP0602523B1 (en) | 1996-12-11 |
GR3022136T3 (en) | 1997-03-31 |
FI935578A (en) | 1994-06-16 |
CA2111386A1 (en) | 1994-06-16 |
NO934604L (en) | 1994-06-16 |
AU672246B2 (en) | 1996-09-26 |
HU9303577D0 (en) | 1994-04-28 |
ES2096840T3 (en) | 1997-03-16 |
DE59304748D1 (en) | 1997-01-23 |
JP3780004B2 (en) | 2006-05-31 |
CA2111386C (en) | 2006-11-14 |
ATE146170T1 (en) | 1996-12-15 |
JPH06239828A (en) | 1994-08-30 |
DK0602523T3 (en) | 1997-06-02 |
HU217634B (en) | 2000-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU672246B2 (en) | Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them | |
HUT63379A (en) | Process for producing aminosubstituted benzoylguanidine derivatives and pharmaceutical compositions comprising such active ingredient | |
AU3132489A (en) | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | |
NO940563D0 (en) | Substituted benzoylquanidines, processes for their preparation, their use as a medicament or diagnostic, as well as drugs containing them | |
AU3301593A (en) | 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament or diagnostic and medicament containing them | |
AU6881194A (en) | Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
AU4163593A (en) | 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them | |
AU6454394A (en) | Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them | |
IL110625A0 (en) | Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical compositions containing them | |
MX9605538A (en) | Benzoyl-guanidines substituted with sulfonylamine, process for their preparation, their use as medicament or for diagnosis, as well as medicament containing them. | |
MX9703871A (en) | Bis-orto substituted benzoylguanidines, process for their preparation, their employment as medicament or diagnosis agent, as well as medicament containing them. | |
MX9703921A (en) | Substituted 1-naphthoylguanidines, process for their preparation, their employment as medicament or diagnosis agent, as well as medicament containing them. | |
MX9703922A (en) | Substituted 1-naphthoylguanidines, process for their preparation, their employment as medicament or diagnosis agent, as well as medicament containing them. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |